These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9527509)

  • 1. Neuropeptide Y Y1 receptor blockade does not alter adrenergic nerve responses of the rat tail artery.
    Duckles SP; Adner M; Edvinsson L; Krause DN
    Eur J Pharmacol; 1997 Dec; 340(1):75-9. PubMed ID: 9527509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of potentiation of Leu31 Pro34 neuropeptide Y on adrenergic and purinergic transmission in isolated canine splenic artery.
    Yang XP; Chiba S
    Jpn J Pharmacol; 2000 Jul; 83(3):197-205. PubMed ID: 10952068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIBP3226 inhibits neuropeptide Y and pancreatic polypeptide potentiated neurogenic vasoconstriction.
    Barrios VE; Nelson AG; Toombs CF
    Life Sci; 1998; 62(6):525-32. PubMed ID: 9464464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
    Malmstrom RE; Lundberg JM
    Eur J Pharmacol; 1995 Dec; 294(2-3):661-8. PubMed ID: 8750731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
    Gicquiaux H; Tschöpl M; Doods HN; Bucher B
    Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats.
    Zhao XH; Sun XY; Bergdahl A; Edvinsson L; Hedner T
    J Pharm Pharmacol; 1999 Nov; 51(11):1257-65. PubMed ID: 10632083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y selectively potentiates alpha1-adrenoceptor-mediated contraction through Y1 receptor subtype in rat femoral artery.
    Tsurumaki T; Honglan P; Higuchi H
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S33-7. PubMed ID: 14871026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
    Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
    Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
    Yang XP; Chiba S
    Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
    Chen SH; Cheung RT
    Neuroscience; 2003; 116(1):119-26. PubMed ID: 12535945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of neuropeptide Y Y1 receptors by BIBP3226 in rat and human epithelial preparations.
    Tough IR; Cox HM
    Eur J Pharmacol; 1996 Aug; 310(1):55-60. PubMed ID: 8880067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
    Oellerich WF; Malik KU
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation.
    Racchi H; Schliem AJ; Donoso MV; Rahmer A; Zúñiga A; Guzmán S; Rudolf K; Huidobro-Toro JP
    Eur J Pharmacol; 1997 Jun; 329(1):79-83. PubMed ID: 9218687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
    Bradley E; Law A; Bell D; Johnson CD
    Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2007-14. PubMed ID: 12742824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo.
    Malmström RE; Modin A; Lundberg JM
    Eur J Pharmacol; 1996 Jun; 305(1-3):145-54. PubMed ID: 8813545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate modulation of neuropeptide Y1 receptor on purinergic and on adrenergic neuroeffector transmission in canine splenic artery.
    Yang XP; Chiba S
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S17-20. PubMed ID: 11811353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.
    Rudolf K; Eberlein W; Engel W; Wieland HA; Willim KD; Entzeroth M; Wienen W; Beck-Sickinger AG; Doods HN
    Eur J Pharmacol; 1994 Dec; 271(2-3):R11-3. PubMed ID: 7705422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptors.
    Vanderheyden PM; Van Liefde I; De Backer JP; Vauquelin G
    Eur J Pharmacol; 1997 Jul; 331(2-3):275-84. PubMed ID: 9274990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.